These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24677715)

  • 21. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
    Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
    Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
    Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
    J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells.
    Wen F; Yang Y; Jin D; Sun J; Yu X; Yang Z
    Biochem Biophys Res Commun; 2014 Mar; 445(2):517-23. PubMed ID: 24548410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
    Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
    J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
    Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
    Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
    Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells.
    Pandey AK; Verma G; Vig S; Srivastava S; Srivastava AK; Datta M
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):125-33. PubMed ID: 20943204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
    Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
    J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway.
    Li CH; Tang SC; Wong CH; Wang Y; Jiang JD; Chen Y
    Eur J Pharmacol; 2018 Apr; 825():107-118. PubMed ID: 29477657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De-silencing
    Luo L; Jiang W; Liu H; Bu J; Tang P; Du C; Xu Z; Luo H; Liu B; Xiao B; Zhou Z; Liu F
    J Mol Endocrinol; 2018 May; 60(4):285-297. PubMed ID: 29555819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
    Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
    J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.
    Sud N; Zhang H; Pan K; Cheng X; Cui J; Su Q
    J Nutr Biochem; 2017 May; 43():125-131. PubMed ID: 28284064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN.
    Fan J; Li H; Nie X; Yin Z; Zhao Y; Chen C; Wen Wang D
    Oncotarget; 2017 Feb; 8(8):13450-13463. PubMed ID: 28088781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway.
    Jiang X; Ruan XL; Xue YX; Yang S; Shi M; Wang LN
    Oxid Med Cell Longev; 2020; 2020():8708236. PubMed ID: 32104542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
    Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
    Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation and mechanism of mouse miR-130a/b in metabolism-related inflammation.
    Zheng H; Dong X; Liu N; Xia W; Zhou L; Chen X; Yang Z; Chen X
    Int J Biochem Cell Biol; 2016 May; 74():72-83. PubMed ID: 26923288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.